Albert Dashi News Today

New technology G2 specifically affects the acne-causing Cutibacterium acnes bacteria strain to “significantly improve acne pathophysiology’ without affecting non-acneic C. acnes strains or staphylococci.

/PRNewswire/ -- Sequential Skin Inc. ("Sequential"), the skin microbiome company developing next generation non-invasive skin testing and data-driven solutions...

Zühlke collaborates with Sequential Skin to design and build a personalised microbiome skincare experience focused on digital scalability, security and quality.

LONDON and NEW YORK and SINGAPORE, June 29, 2022 /PRNewswire/ --Sequential Skin Ltd, a leading skin genomics start-up, has been awarded an Innovate UK SMART Grant to fund a project on advancing current understanding of the skin microbiome in healthy and diseased skin - using their novel testing kits. Atopic dermatitis (AD) is a multifactorial chronic and recurrent inflammatory skin disease, affecting 20% of children and 10% of adults. Roughly 29% are moderate to severe cases, with healthcare and...

LONDON and NEW YORK and SINGAPORE, June 29, 2022 /PRNewswire/ -- Sequential Skin Ltd, a leading skin genomics start-up, has been awarded an Innovate UK SMART Grant to fund a project on advancing

/PRNewswire/ -- Sequential Skin Ltd, a UK/Singapore biotech start-up has raised US $1.65M in its oversubscribed seed round – to revolutionise the future of...

UK-Singapore headquartered biotech startup Sequential Skin has secured more funding in its latest seed round that it plans to use for global expansion of its at-home skin diagnostics patch, in both a B2B and D2C capacity, its CEO says.